The association between serum adiponectin levels and the severity of coronary artery lesions on the angiogram;Serum adiponektin düzeyleri ile anjiyogramda koroner lezyon ciddiyeti arasindaki ilişki

Turk Kardiyoloji Dernegi Arsivi

Volumn 37, Issue 4, 2009, Pages 241-245

  Göksoy, Hidayet ^a   Dursunoǧlu, Dursun ^a   Öztürk, Mehmet ^a   Rota, Simin ^b  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Biyokimya Anabilim Dali   (Turkey)

Author keywords

Adiponectin; Biological markers; Coronary angiography; Coronary artery disease blood classification

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; RADIOGRAPHY;

ADIPONECTIN; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 77951637110     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
2. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43. (Pubitemid 34212626)
3. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-9. (Pubitemid 36091630)
4. Han SH, Quon MJ, Kim JA, Koh KK. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 2007;49:531-8. (Pubitemid 46177440)
5. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-6. (Pubitemid 30005109)
6. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-49. (Pubitemid 40712793)
7. Salmenniemi U, Ruotsalainen E, Pihlajamäki J, Vauhkonen I, Kainulainen S, Punnonen, et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 2004;110:3842-8. (Pubitemid 40023983)
8. Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Takefuji S, et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 2006;26:871-6. (Pubitemid 43732165)
9. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-9. (Pubitemid 30353893)
10. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-5. (Pubitemid 32472900)
11. Giannessi D, Maltinti M, Del Ry S. Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk. Pharmacol Res 2007;56:459-67. (Pubitemid 350137773)
12. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606. (Pubitemid 13187192)
13. Liang KW, Sheu WH, Lee WL, Liu TJ, Ting CT, Hsieh YC, et al. Decreased circulating protective adiponectin level is associated with angiographic coronary disease progression in patients with angina pectoris. Int J Cardiol 2008;129:76-80.
14. Çavuşoǧlu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006;27:2300-9. (Pubitemid 44453573)
15. Otsuka F, Sugiyama S, Kojima S, Maruyoshi H, Funahashi T, Matsui K, et al. Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol 2006;48:1155-62. (Pubitemid 44345143)
16. Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y, et al. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol 2007;100:569-74. (Pubitemid 47223129)
17. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730-7 (Pubitemid 38489895)
18. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000;32:47-50. (Pubitemid 30143606)
19. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta 2004;344:1-12. (Pubitemid 38626132)
20. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003;278:45021-6. (Pubitemid 37377262)
21. Patel JV, Abraheem A, Dotsenko O, Creamer J, Gunning M, Hughes EA, et al. Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function. J Intern Med 2008;264:593-8.